Drugs / Avaxim 80U Pediatric
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02011763 | Dec 2013 → Sep 2014 | hepatitis A virus infection | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Avaxim 80U Pediatric | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02011763 ↗ |
| Modality | Vaccine | “Inactivated Hepatitis A Vaccine” NCT02011763 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular (2 injection 6 months apart)” NCT02011763 ↗ |